Success Metrics

Clinical Success Rate

80.0%

Based on 4 completed trials

Completion Rate

80%(4/5)

Active Trials

0(0%)

Results Posted

75%(3 trials)

Terminated

1(20%)

Phase Distribution

Ph not_applicable

60%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

N/ANon-phased studies

3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Terminated(1)

Detailed Status

Completed4

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

80.0%

Most Advanced

N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed480%

terminated120%

Recent Activity

0 active trials

Showing 5 of 5

completed

Sacral Neuromodulation and the Microbiome

NCT02833402

completednot_applicable

InterStim® Amplitude Study

NCT03335761

terminatednot_applicable

Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder

NCT01023269

completednot_applicable

InterStim Therapy Programming Study

NCT01009333

completed

A Cost Analysis of Interstim Therapy

NCT00200031

Clinical Trials (5)

Showing 5 of 5 trials

NCT02833402

Sacral Neuromodulation and the Microbiome

Completed

NCT03335761Not Applicable

InterStim® Amplitude Study

Completed

NCT01023269Not Applicable

Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder

Terminated

NCT01009333Not Applicable

InterStim Therapy Programming Study

Completed

NCT00200031

A Cost Analysis of Interstim Therapy

Completed

All 5 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 5